[HTML][HTML] Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology

K Novović, B Jovčić - Antibiotics, 2023 - mdpi.com
Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review

N Gupta, K Angadi, S Jadhav - Infection and Drug Resistance, 2022 - Taylor & Francis
Carbapenemases are β-lactamase enzymes that hydrolyze a variety of β-lactams including
carbapenem and belong to different Ambler classes (A, B, D). These enzymes can be …

Isolation of extensively drug resistant Acinetobacter baumannii from environmental surfaces inside intensive care units

Q Ababneh, S Abulaila, Z Jaradat - American Journal of Infection Control, 2022 - Elsevier
Background Acinetobacter baumannii is a nosocomial pathogen that has emerged as a
major threat in the health-care settings, particularly intensive care units (ICUs). The aim of …

[HTML][HTML] Molecular characterization of multidrug resistant Acinetobacter baumannii clinical isolates from Alexandria, Egypt

S Sanchez-Urtaza, A Ocampo-Sosa… - Frontiers in Cellular …, 2023 - frontiersin.org
Carbapenem resistant Acinetobacter baumannii is a major global concern, especially in
countries of the Middle East and North Africa, where the antibiotic resistance rates are on the …

[HTML][HTML] Insights into mucoid Acinetobacter baumannii: A review of microbiological characteristics, virulence, and pathogenic mechanisms in a threatening nosocomial …

W Shan, J Kan, X Cai, M Yin - Microbiological Research, 2022 - Elsevier
Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen and leading cause of
health care-associated infections. Several known pathogenic factors, including …

[HTML][HTML] Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol …

S Gaillot, S Oueslati, JB Vuillemenot, M Bour… - Frontiers in …, 2023 - frontiersin.org
Here, we characterized the first French NDM-9-producing Acinetobacter baumannii isolate.
A. baumannii 13A297, which belonged to the STPas25 (international clone IC7), was highly …

[HTML][HTML] Multidrug-Resistant Acinetobacter baumannii Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions

WH Elwakil, SS Rizk, AM El-Halawany, ME Rateb… - Antibiotics, 2023 - mdpi.com
Acinetobacter baumannii is a problematic pathogen of global concern. It causes multiple
types of infection, especially among immunocompromised individuals in intensive care units …

[HTML][HTML] Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons

MM Zafer, AFA Hussein, MH Al-Agamy… - Frontiers in Cellular …, 2023 - frontiersin.org
The progressive increase in the resistance rates to first-and second-line antibiotics has
forced the reuse of colistin as last-line treatment for Acinetobacter baumannii infections, but …

[HTML][HTML] Laboratory Surveillance of Acinetobacter spp. Bloodstream Infections in a Tertiary University Hospital during a 9-Year Period

A Spiliopoulou, I Giannopoulou… - Tropical Medicine and …, 2023 - mdpi.com
Multidrug-resistant Acinetobacter baumannii infections have become a threat for public
health worldwide. The aim of the present study was to follow-up resistance patterns of …

Deciphering multidrug-resistant Acinetobacter baumannii from a pediatric cancer hospital in Egypt

D Jalal, MG Elzayat, AA Diab, HE El-Shqanqery… - Msphere, 2021 - Am Soc Microbiol
Infection by multidrug-resistant (MDR) Acinetobacter baumannii is one of the major causes
of hospital-acquired infections worldwide. The ability of A. baumannii to survive in adverse …